Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
Margherita Bersani, Mafalda Rizzuti, Elisa Pagliari, et al.
Molecular Therapy (2021) Vol. 30, Iss. 3, pp. 1288-1299
Open Access | Times Cited: 20

Showing 20 citing articles:

A Historical Review of Brain Drug Delivery
William M. Pardridge
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 132
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides
So Hee Nam, Joonhyuck Park, Heebeom Koo
Archives of Pharmacal Research (2023) Vol. 46, Iss. 1, pp. 18-34
Open Access | Times Cited: 43
Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides
Florina Zákány, István M. Mándity, Zoltán Varga, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1700-1700
Open Access | Times Cited: 18
Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide
Umme Sabrina Haque, Toshifumi Yokota
Cells (2023) Vol. 12, Iss. 19, pp. 2395-2395
Open Access | Times Cited: 13
DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration
Tejal Aslesh, Esra Erkut, Jun Ren, et al.
JCI Insight (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 11
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
Genes (2024) Vol. 15, Iss. 8, pp. 999-999
Open Access | Times Cited: 4
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
(2024)
Open Access | Times Cited: 3
Therapeutic targeting of RNA for neurological and neuromuscular disease
Jodi L. Bubenik, Marina M. Scotti, Maurice S. Swanson
Genes & Development (2024)
Open Access | Times Cited: 3
AI-Driven Design of Cell-Penetrating Peptides for Therapeutic Biotechnology
Hongru Ma, Xinzhi Zhou, Ziyue Zhang, et al.
International Journal of Peptide Research and Therapeutics (2024) Vol. 30, Iss. 6
Closed Access | Times Cited: 3
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
Jamie Leckie, Toshifumi Yokota
(2024)
Open Access | Times Cited: 2
Cell-Penetrating Peptides in infection and immunization
Yongliang Du, Yan Xiong, Zhou Sha, et al.
Microbiological Research (2024) Vol. 290, pp. 127963-127963
Closed Access | Times Cited: 2
Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles
Kamil Bakowski, Stefan Vogel
RNA Biology (2022) Vol. 19, Iss. 1, pp. 1256-1275
Open Access | Times Cited: 12
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
Irene González-Martínez, Estefanía Cerro-Herreros, Nerea Moreno, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102024-102024
Open Access | Times Cited: 6
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
Jamie Leckie, Toshifumi Yokota
Molecules (2024) Vol. 29, Iss. 11, pp. 2658-2658
Open Access | Times Cited: 1
A Chemical Biology Perspective to Therapeutic Regulation of RNA Splicing in Spinal Muscular Atrophy (SMA)
Lei Zhang, Frank Abendroth, Olalla Vázquez
ACS Chemical Biology (2022) Vol. 17, Iss. 6, pp. 1293-1307
Closed Access | Times Cited: 5
Engraulisin: A novel marine derived cell penetrating peptide with activity against drug resistant bacteria
Saurabh Saraswat, Archana Chugh
Biochimica et Biophysica Acta (BBA) - Biomembranes (2023) Vol. 1866, Iss. 2, pp. 184255-184255
Closed Access | Times Cited: 2
Peptide-based therapeutics targeting genetic disorders
Shweta Subramanian, Meenakshi Jain, Rajkumar Misra, et al.
Drug Discovery Today (2024), pp. 104209-104209
Closed Access
Therapeutic Potential of CPPs
Ülo Langel
Springer eBooks (2023), pp. 407-467
Closed Access | Times Cited: 1
The complexing of cationic copolymer MPC30-DEA70with TGF-β1 antisense oligodeoxynucleotide and transfection into cardiomyocytesin vitro
Godfred Amfo Agyekum, Min Zhang, Fei Li, et al.
Journal of Biomaterials Applications (2022) Vol. 37, Iss. 7, pp. 1315-1324
Closed Access
PPMOs: A Case Study for Cell‐Penetrating Peptide Application
Scott Bittner, Zoe X. Moulton, Hong M. Moulton
(2022), pp. 263-284
Closed Access
Page 1

Scroll to top